PREDICTORS OF ATYPICAL CHEST IMAGING IN PATIENTS WITH PULMONARY TUBERCULOSIS
DOI:
https://doi.org/10.54112/bcsrj.v2024i1.702Keywords:
Computed Tomography, Imaging, Pulmonary tuberculosis, RadiologyAbstract
This study aimed to identify the risk factors associated with abnormal chest imaging in patients diagnosed with pulmonary tuberculosis. A retrospective study was conducted between December 2022 and December 2023 in the Radiology Department of Mayo Hospital, Lahore. The study included 100 patients who were diagnosed with smear-positive pulmonary tuberculosis and had undergone chest computed tomography (CT) within two weeks before or after hospital admission. Patients' performance status was assessed on a scale of 0-4. CT scans were performed on all patients, and radiologists were unaware of the patient's data. They examined the scans to determine the presence of lung involvement (upper, middle, and lower) and cavity. Out of 100 patients, 48 (48%) had non-cavity disease. Univariate analysis revealed that patients with non-cavity disease were most likely to be female, older, and have low estimated glomerular filtration rate (eGFR) and C-reactive protein (CRP) levels compared to patients with cavities. In multivariate analysis, low CRP levels were found to be the most potent risk factor for non-cavity disease after adjusting for co-variables. Additionally, 70 patients (70%) presented with non-upper predominant lung disease. Univariate analysis revealed that the majority of patients in this group were women and had high CRP levels, low albumin levels, and poor performance status. Poor performance status was the most potent risk factor for non-upper predominant lung disease. Based on the study findings, low C-reactive protein levels and poor performance status are the most substantial risk factors for non-cavity and non-upper predominant lung disease, respectively, in patients with pulmonary tuberculosis.
Downloads
References
Abolhassani, A.-R., Schuler, G., Kirchberger, M. C., and Heinzerling, L. (2019). C-reactive protein as an early marker of immune-related adverse events. Journal of Cancer Research and Clinical Oncology 145, 2625-2631.
Aggarwal, A. N. (2019). Quality of life with tuberculosis. Journal of clinical tuberculosis and other mycobacterial diseases 17, 100121.
Barreda, N. N., Arriaga, M. B., Aliaga, J. G., Lopez, K., Sanabria, O. M., Carmo, T. A., Fróes Neto, J. F., Lecca, L., Andrade, B. B., and Calderon, R. I. (2020). Severe pulmonary radiological manifestations are associated with a distinct biochemical profile in blood of tuberculosis patients with dysglycemia. BMC Infectious Diseases 20, 1-14.
Behzadmehr, R., and Rezaie-Keikhaie, K. (2022). Evaluation of active pulmonary tuberculosis among women with diabetes. Cellular, Molecular and Biomedical Reports 2, 56-63.
Bello, S., Afolabi, R. F., Ajayi, D. T., Sharma, T., Owoeye, D. O., Oduyoye, O., and Jasanya, J. (2019). Empirical evidence of delays in diagnosis and treatment of pulmonary tuberculosis: systematic review and meta-regression analysis. BMC public health 19, 1-11.
Curry, B., Maasdorp, E., Nortje, A., Irusen, E., Maree, D., Koegelenberg, C., and Allwood, B. (2022). Correlation between lung function tests and peak oxygen consumption in post-TB lung disease. The International Journal of Tuberculosis and Lung Disease 26, 259-267.
Getnet, F., Demissie, M., Worku, A., Gobena, T., Seyoum, B., Tschopp, R., and Andersen, C. T. (2019a). Determinants of patient delay in diagnosis of pulmonary tuberculosis in Somali Pastoralist Setting of Ethiopia: a matched case-control study. International journal of environmental research and public health 16, 3391.
Getnet, F., Demissie, M., Worku, A., Gobena, T., Tschopp, R., Girmachew, M., Assefa, G., and Seyoum, B. (2019b). Delay in diagnosis of pulmonary tuberculosis increases the risk of pulmonary cavitation in pastoralist setting of Ethiopia. BMC pulmonary medicine 19, 1-10.
Goto, A., Komiya, K., Kan, T., Honjo, K., Uchida, S., Takikawa, S., Yoshimatsu, T., Fujimoto, K., Johkoh, T., and Kadota, J.-i. (2019). Factors associated with atypical radiological findings of pulmonary tuberculosis. Plos one 14, e0220346.
Hikone, M., Ainoda, Y., Sakamoto, N., and Ohnishi, K. (2020). Clinical characteristics of elderly pulmonary tuberculosis in an acute-care general hospital in Tokyo, Japan: a 12-year retrospective study. Journal of Infection and Chemotherapy 26, 245-250.
Honjo, K., Komiya, K., Kan, T., Uchida, S., Goto, A., Takikawa, S., Yoshimatsu, T., Wong, Z. S., Takahashi, O., and Kadota, J.-i. (2020). The impact of performance status on tuberculosis-related death among elderly patients with lung tuberculosis: a competing risk regression analysis. Journal of Infection and Chemotherapy 26, 69-75.
Huangfu, P., Ugarte-Gil, C., Golub, J., Pearson, F., and Critchley, J. (2019). The effects of diabetes on tuberculosis treatment outcomes: an updated systematic review and meta-analysis. The International Journal of Tuberculosis and Lung Disease 23, 783-796.
Nakao, M., Muramatsu, H., Arakawa, S., Sakai, Y., Suzuki, Y., Fujita, K., and Sato, H. (2019). Immunonutritional status and pulmonary cavitation in patients with tuberculosis: A revisit with an assessment of neutrophil/lymphocyte ratio. Respiratory investigation 57, 60-66.
Nel, M., Franckling-Smith, Z., Pillay, T., Andronikou, S., and Zar, H. J. (2022). Chest imaging for pulmonary TB—An update. Pathogens 11, 161.
Zhang, C.-Y., Zhao, F., Xia, Y.-Y., Yu, Y.-L., Shen, X., Lu, W., Wang, X.-M., Xing, J., Ye, J.-J., and Li, J.-W. (2019). Prevalence and risk factors of active pulmonary tuberculosis among elderly people in China: a population based cross-sectional study. Infectious Diseases of Poverty 8, 26-35.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 A SHAKIR , S MAZHAR , A NOREEN , I SHAHZAD , NA BUGVI , Z SHAHID
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
